Infinity Pharmaceuticals Inc. (INFI) Declined -5.71% or -0.1 To Price $1.74 On Wednesday


Infinity Pharmaceuticals Inc. (INFI) declined -5.71% or -0.1 to $1.74. It is close to 394265 shares traded, which is 62.47% compare to the average total volume 631155. The market cap of INFI is $97.28 million. The year to date change is -23.2%. The 52 week price range is from $0.93 to $3.75. Price of INFI have changed -6.12% during last week. It have changed -9.36% over last month, -14.81% over last 3 months, -11.96% over last 6 months and 31.43% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for INFI is 1.94. It is 11.49% above current price. The 200-day Moving Averages for INFI is 2.08. It is 19.54% above current price. The 52-week High is 3.75. It is 115.52% from the current price. The 52-week Low is 0.93. It is -46.55% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of INFI is 1.72 on 2018-06-29. Short % to float is 3.02%. There are some statistics of INFI. It is has market cap $97.28 million. The share outstanding is 56.07 million. The average volume is 631155. The revenue is 6.00M. The percent of top 15 Institution holding is 59.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of INFI is -68.47%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of INFI is -53.14%.


Tags:

Share this post